Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

Uchenna Agbim, Yu Jiang, Satish K. Kedia, Ashwani K. Singal, Aijaz Ahmed, Kalyan Ram Bhamidimarri, David E. Bernstein, Stephen A. Harrison, Zobair M. Younossi, Sanjaya K. Satapathy – 9 August 2018 – Nonalcoholic fatty liver disease is an increasingly prevalent condition, and its more severe progressive state, nonalcoholic steatohepatitis (NASH), is currently the second most common indication for wait‐listed adults in the United States.

Subscribe to